Bafnapharm Cash Flow Annual

Trade
BSE: 532989 | NSE: BAFNAPH | ISIN: INE878I01022 | Sector: Biotechnology & Drugs
81.74 +1.74 (2.18%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 7.3511.775.195.83
Depreciation/ Depletion 5.005.335.494.48
Non- Cash Items 3.031.621.57-0.66
Changesin Working Capital -5.89-13.77-2.53-23.25
Cashfrom Operating Activities 9.484.959.73-13.61
Capital Expenditures -15.85-8.22-7.54-6.09
Other Investing Cash Flow Items Total 0.790.731.000.75
Cashfrom Investing Activities -15.05-7.49-6.54-5.35
Financing Cash Flow Items -2.31-1.69-0.09-0.09
Issuance( Retirement)of Debt Net 1.4711.86-4.7312.37
Cashfrom Financing Activities -0.8510.18-4.8112.28
Net Changein Cash -6.417.64-1.63-6.68
Cash Interest Paid 2.311.690.090.09
Cash Taxes Paid 0.170.130.17-
Issuance( Retirement)of Stock Net ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts